Pay in 4 interest-free payments of $7.09 Learn more
Ships within 48 hours · Estimated delivery Oct 1 - Oct 6
Protective effect of shikimic acid against cisplatin-induced renal injury: in vitro and in vivo studies
Description For In Vitro Research Use Only Not for Human or Veterinary Application Specifications: Quantity: 5 mg Form: Lyophilized Powder Intended Use: This compound is intended strictly for in vitro laboratory research by qualified professionals
Oral administration of allicin to mice lowered ROS production and prevented ROS-induced cardiac hypertrophy by inhibiting pro-inflammatory pathways like mitogen-activated protein kinase (MAPK) and phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt)/glycogen synthase kinase 3 (GSK3) signaling pathways (20)
Being FDA-approved implies that this peptide is often prescribed to patients diagnosed with diabetes mellitus, hypertension, or hypercholesterolemia
US$ 26.78
US$ 24.03
US$ 22.96
US$ 22.83
US$ 26.06
US$ 23.09
US$ 28.35
